Pharmacovigilance – Webinars and Online Events
Generation and Characterization of Retinal Organoids From iPSCs
The Dash for NASH: How To Succeed in NASH Therapeutic Development
Despite continued research and development efforts, not one NASH therapeutic agent has made it to market yet. Traditional preclinical tests have repeatedly failed to predict human drug efficacy as they inadequately recreate the complexity and multifaceted nature of this human disease. As a result, NASH is poised to become a global health and economic burden.
Is it time to increase your chances of clinical success with a new human-relevant approach to drug discovery and development?
Protein Biomarker Models for Oncology Risk Assessment and Treatment Monitoring
Multi-Modal Connected Workflow for Cardiac Safety Assessment of Drugs Using hiPSC-Derived Cardiomyocytes Session 2
Multi-Modal Connected Workflow for Cardiac Safety Assessment of Drugs Using hiPSC-Derived Cardiomyocytes Session 1
Improving Cognitive and Gait Control in Parkinson’s with Vagus Nerve Stimulation
In this webinar, we will summarise the current literature on non-invasive VNS in Parkinson’s disease and discuss preliminary findings of its therapeutic potential with an emphasis on its efficacy in improving cognitive and gait control in people with Parkinson’s.